首页> 外国专利> Method for cardiomyocyte maturation on amniotic fluid cell-derived ECM, cell structure, and use for cardiac toxicity and anterior vein screening of drug compounds

Method for cardiomyocyte maturation on amniotic fluid cell-derived ECM, cell structure, and use for cardiac toxicity and anterior vein screening of drug compounds

机译:心肌细胞衍生ECM,细胞结构的心肌细胞成熟方法,以及用于药物化合物的心脏毒性和前静脉筛选的用于心脏毒性和前静脉筛选

摘要

Cell-derived extracellular matrix ( AFC-) derived in vitro from cells isolated from amniotic fluid for maturation of immature cardiomyocytes (immature hiPSC-CM) derived from human induced pluripotent stem cells in culture to form mature cardiomyocytes ECM) is disclosed herein. Also disclosed herein are cell structures comprising a monolayer of such mature cardiomyocytes on AFC-ECM useful for cardiac toxicity and/or anterior vein screening assays of drug compounds. Also disclosed herein is a method for determining in vitro the cardiac toxicity and/or anterior venous effect of a drug compound using such cellular structures.
机译:本文公开了本文公开了从从羊皮细胞中分离的细胞中分离的细胞中的细胞衍生的细胞外基质(AFC-)。 本文还公开了细胞结构,其包含对AFC-ECM的这种成熟心肌细胞的单层,可用于药物化合物的心脏毒性和/或前静脉筛选测定。 本文还公开了使用这种细胞结构来确定药物化合物的心脏毒性和/或前静脉作用的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号